These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30820904)

  • 1. Conditional Mutagenesis in Oligodendrocyte Lineage Cells.
    Goebbels S; Nave KA
    Methods Mol Biol; 2019; 1936():249-274. PubMed ID: 30820904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells.
    Leone DP; Genoud S; Atanasoski S; Grausenburger R; Berger P; Metzger D; Macklin WB; Chambon P; Suter U
    Mol Cell Neurosci; 2003 Apr; 22(4):430-40. PubMed ID: 12727441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cre recombinase resources for conditional mouse mutagenesis.
    Smedley D; Salimova E; Rosenthal N
    Methods; 2011 Apr; 53(4):411-6. PubMed ID: 21195764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proteolipid protein promoter drives expression outside of the oligodendrocyte lineage during embryonic and early postnatal development.
    Michalski JP; Anderson C; Beauvais A; De Repentigny Y; Kothary R
    PLoS One; 2011 May; 6(5):e19772. PubMed ID: 21572962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generating conditional knockout mice.
    Friedel RH; Wurst W; Wefers B; Kühn R
    Methods Mol Biol; 2011; 693():205-31. PubMed ID: 21080282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.
    Jäger R; Maurer J; Jacob A; Schorle H
    Genesis; 2004 Mar; 38(3):145-50. PubMed ID: 15048812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CreER(T2) expression from within the c-Kit gene locus allows efficient inducible gene targeting in and ablation of mast cells.
    Heger K; Seidler B; Vahl JC; Schwartz C; Kober M; Klein S; Voehringer D; Saur D; Schmidt-Supprian M
    Eur J Immunol; 2014 Jan; 44(1):296-306. PubMed ID: 24127407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The practical use of Cre and loxP technologies in mouse auditory research.
    Yu Y; Zuo J
    Methods Mol Biol; 2009; 493():87-102. PubMed ID: 18839343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional gene targeting in the mouse nervous system: Insights into brain function and diseases.
    Gavériaux-Ruff C; Kieffer BL
    Pharmacol Ther; 2007 Mar; 113(3):619-34. PubMed ID: 17289150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cre transgenic mouse lines.
    Wang X
    Methods Mol Biol; 2009; 561():265-73. PubMed ID: 19504077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pitx3-CreER mice showing restricted Cre expression in developing ocular lens and skeletal muscles.
    Qiu HY; Guo C; Cheng XW; Huang Y; Xiong ZQ; Ding YQ
    Genesis; 2008 Jun; 46(6):324-8. PubMed ID: 18543300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible site-specific recombination in myelinating cells.
    Doerflinger NH; Macklin WB; Popko B
    Genesis; 2003 Jan; 35(1):63-72. PubMed ID: 12481300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a tamoxifen-inducible Cre-driver mouse strain for widespread and temporal genetic modification in adult mice.
    Ichise H; Hori A; Shiozawa S; Kondo S; Kanegae Y; Saito I; Ichise T; Yoshida N
    Exp Anim; 2016 Jul; 65(3):231-44. PubMed ID: 26923756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-activated site-specific recombination in mice.
    Feil R; Brocard J; Mascrez B; LeMeur M; Metzger D; Chambon P
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10887-90. PubMed ID: 8855277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
    Licht AH; Raab S; Hofmann U; Breier G
    Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practical summary of site-specific recombination, conditional mutagenesis, and tamoxifen induction of CreERT2.
    Anastassiadis K; Glaser S; Kranz A; Berhardt K; Stewart AF
    Methods Enzymol; 2010; 477():109-23. PubMed ID: 20699139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen administration routes and dosage for inducible Cre-mediated gene disruption in mouse hearts.
    Andersson KB; Winer LH; Mørk HK; Molkentin JD; Jaisser F
    Transgenic Res; 2010 Aug; 19(4):715-25. PubMed ID: 19894134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatio-temporally controlled site-specific somatic mutagenesis in the mouse.
    Brocard J; Warot X; Wendling O; Messaddeq N; Vonesch JL; Chambon P; Metzger D
    Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14559-63. PubMed ID: 9405652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial-Specific Cre Mouse Models.
    Payne S; De Val S; Neal A
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2550-2561. PubMed ID: 30354251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.